# The Exploratory Clinical Trials on the Primary Safety and Effectiveness of High Myopic Posterior Scleral Fixation System

> **NCT05034016** · NA · UNKNOWN · sponsor: **GuangZhou WeiShiBo Biotechnology Co., ltd** · enrollment: 20 (estimated)

## Conditions studied

- High Myopia
- Macular Schisis

## Interventions

- **DEVICE:** High Myopic Posterior Scleral Fixation System

## Key facts

- **NCT ID:** NCT05034016
- **Lead sponsor:** GuangZhou WeiShiBo Biotechnology Co., ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-04-24
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034016, "The Exploratory Clinical Trials on the Primary Safety and Effectiveness of High Myopic Posterior Scleral Fixation System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05034016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*